Atlas Trials

The Effect of Memantine on Functional Outcomes and Motor Neuron Degeneration in Amyotrophic Lateral Sclerosis (ALS)

Clinical trial NCT00409721 · COMPLETED

Trial details

NCT number
NCT00409721
Sponsor
University of Alberta
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Amyotrophic Lateral Sclerosis
Start date
2007-03-01
Primary completion
2010-12-01
Enrollment
42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.